Sagent Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT
SAGENT has ninety-two approved drugs.
There is one tentative approval on SAGENT drugs.
Summary for Sagent
| US Patents: | 0 |
| Tradenames: | 72 |
| Ingredients: | 69 |
| NDAs: | 92 |
| Patent Litigation for Sagent: | See patent lawsuits for Sagent |
Drugs and US Patents for Sagent
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | DESMOPRESSIN ACETATE | desmopressin acetate | INJECTABLE;INJECTION | 204751-001 | Aug 22, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms | LEUCOVORIN CALCIUM PRESERVATIVE FREE | leucovorin calcium | INJECTABLE;INJECTION | 200855-001 | Sep 6, 2012 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms Inc | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 201835-001 | Jun 27, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Sagent | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | INJECTABLE;INJECTION | 040540-001 | May 28, 2004 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms Inc | CHLOROTHIAZIDE SODIUM | chlorothiazide sodium | INJECTABLE;INJECTION | 202462-001 | May 29, 2015 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

